Contact
Please use this form to send email to PR contact of this press release:
Lion Biotechnologies Announces First Patient Dosed in Second Cohort of LN-144 Phase 2 Trial for Metastatic Melanoma
TO:
Please use this form to send email to PR contact of this press release:
Lion Biotechnologies Announces First Patient Dosed in Second Cohort of LN-144 Phase 2 Trial for Metastatic Melanoma
TO: